DAFTAR PUSTAKA
1. El-Zimaity HMT. Recent advances in the histopathology of gastritis. Current Diagnostic Pathology: 2007; 13:340-8.
2. Rugge M, Genta RM. Staging and grading of chronic gastritis. Human pathology: 2005; 36:228-33.
3. Fox JG, Wang TC. Inflammation, atrophy and gastric cancer. The Journal of Clinical Investigation: 2007; 17:60-9.
4. Cesar ACG, Cury PM, Payao SLM. Comparison of histological and molecular diagnosis of Helicobacter pylori in benign lesions and gastric adenocarcinoma. Braz J Microbiol: 2005; 36(1):261-6.
5. Rehnberg-Laiho L, Rautelin H, Koskela P, Sarna S, Pukkala E, Aromaa A, et al. Decreasing prevalence of helicobacter antibodies in Finland, with reference to the decreasing incidence of gastric cancer. Epidemiol Infect: 2001; 126:37-42.
6. Matsukura N, Yamada S, Kato S, Tomtitchong P, Tajiri T, Miki M, et al. Genetic differences in interleukin-1 betapolymorphisms among four Asian populations: an analysis of the Asian paradox between H. pylori infection and gastric cancer incidence. J Exp Clin Cancer Res: 2003; 22: 47-55. 7. Xuan J, Deguchi R, Yanagi H, Ozawa H, Urano T, Ogawa Y, et al.
Relationship between gastric mucosal IL-8 levels and histological gastritis in patients with Helicobacter pylori infection. Tokai J Exp Clin Med: 2005; 30(2):83-8.
8. Andersen LP, Holck S, Janulaityte-Gu¨nther D, Kupcinskas L, Kiudelis G, Jonaitis L, et al. Gastric inflammatory markers and interleukins in patients with functional dyspepsia, with and without Helicobacter pylori infection.
9. Toljamo K. Gastric erosions – clinical significance and pathology. A long-term follow-up study. University of Oulu, Finland:Acta Univ Oul: 2012: hlm 1-80.
10.S. Ilyas. Repository. Usu.ac.id 2013
11.Dixon MF, Genta RM, Yardley H, Correa P. Classification and grading of gastritis: the updated Sydney system. Am J Surg Pathol. 1996;20:1161–81. 12.Aydin O, Egilmez R, Karabacak T, Kanik A. Interobserver variation in
histopathological assessment of Helicobacter pylori gastritis.World J Gastroenterol. 2003; 9: 2232-5.
13.Szoke D. Genetic factors related to the histological and macroscopic lesions of the stomach. [disertasi]. Budapest: Semmelweis University; 2009. Hlm 7-61.
14.Guindy AE, Ghoraba H. A study of the concordance between endoscopic gastritis and histological gastritis in nonulcer dyspeptic patients with and without Helicobacter pylori infection. Tanta Medical Sciences Journal. 2007;2(2):67-82.
15.Adibi P. Gastritis. [Diunduh 19 Mei 2014]. Tersedia dari: http://med.mui.ac.ir
16.Wehbi M, Acute gastritis Medscape. 2014
17.Simadibrata M. Dyspepsia and Gastroesophageal Reflux Disease (GERD): Is There Any Correlation? Acta Med Indones. 2009; 41(4): 222-7.
18.Silva MIG, de Sousa FCF. Gastric ulcer etiology. In: Chai J, editor. Peptic Ulcer Disease. Shanghai: Intech; 2011. hlm. 3-28.
19.Loyd RA, McClellan DA. Update on the evaluation and management of functional dyspepsia. Am Fam Physician. 2011;83(5):547-52.
20.Mueller A, Merrel DS, Grimm J, Falkow S. Profiling of microdissected gastric epithelial cells reveals a cell-type specific response to Helicobacter pylori infection. Gastroenterology. 2004;127:1446–62.
22.Brzozowski T, Konturek PC, Konturek SJ, Brzozowska I, Pawlik T. Role of prostaglandins in gastroprotection and gastric adaptation. Journal of physiology and pharmacology. 2005; 56(Suppl 3):33-55.
23.Blaser
EMBO Reports. 2006;7(10): 956–60.
24.Fischer W, Puls J, Buhrdorf R, Gebert B, Odenbreit S, Haas R. Systematic mutagenesis of the Helicobacter pylori cag pathogenicity island: essential genes for CagA translocation in host cells and induction of interleukin-8. Mol Microbiol. 2001; 42:1337-48.
25.Holck S, Norgaard A, Bennedsen M, Permin H, Norn S, Andersen LP, et al. Gastric mucosal cytokine responses in Helicobacter pylori-infected patients with gastritis and peptic ulcers. Association with inflammatory parameters and bacteria load. FEMS Immunology and Medical Microbiology. 2003;36:175-80.
26.Farinati F, Cardin R, Russo VM, Busatto G, Franco M, Rugge M. Helicobacter pylori CagA status, mucosal oxidative damage and gastritis phenotype: a potential pathway to cancer? Helicobacter. 2003; 8:227-34.
27.Farinati F, Cardin R, Russo VM, Busatto G, Franco M, Rugge M. Helicobacter pylori CagA status, mucosal oxidative damage and gastritis phenotype: a potential pathway to cancer? Helicobacter. 2003; 8:227-34. 28.Kusters JG, van Vliet AH, Kuipers EJ. Pathogenesis of Helicobacter
pylori infection. Clin Microbiol Rev. 2006; 19:449-90.
29.Pelicic V, Reyrat JM, Sartori L, Pagliaccia C, Rappuoli R, Telford JL, et al. Helicobacter pylori VacA cytotoxin associated with the bacteria increases epithelial permeability independently of its vacuolating activity. Microbiology. 1999;145(8): 2043-50.
31.Zhang Z, Zheng Q, Chen X, Xiao S, Liu W, Lu H. The Helicobacter pylori duodenal ulcer promoting gene, dupA in China. BMC Gastroenterol. 2008;8:49-54.
32.Lu H, Hsu PI, Graham DY, Yamaoka Y. Duodenal ulcer promoting gene of Helicobacter pylori. Gastroenterology. 2005;128:833-48.
33.Yamaoka Y, Kodama T, Kita M, Imanishi J, Kashima K, Graham DY. Relation between cytokines and Helicobacter pylori in gastric cancer. Helicobacter. 2001;6(2):116-24.
34.Rad R, Gerhard M, Lang R, Schoniger M, Rosch T, Schepp W, et al. The Helicobacter pylori blood group antigen-binding adhesin facilitates bacterial colonization and augments a nonspecific immune response. J Immunol. 2002;168: 3033-41.
35.Montecucco C, de Bernard M. Molecular and cellular mechanisms of action of the vacuolating cytotoxin (VacA) and neutrophil-activating protein (HP-NAP) virulence factors of Helicobacter pylori. Microbes Infect. 2003;5:715-21.
36.Banerjee A, Mukhopadhyay AK, Paul S, Bhattacharyya A and Swarnakar S. Unveiling the Intricacies of Helicobacter pylori-induced Gastric Inflammation: T Helper cells and Matrix Metalloproteinases at a Crossroad. In: Mozsik G, editor. Current Topics in Gastritis. Croatia: InTech Publishers; 2013. Chapter 7.
37.Zakaria Z, Devaney RJ, Atherthon JC, Robinson K. Effects of interleukin-10 on the gastric epithelial cell response to Helicobacter pylori. In 8th International Workshop on Pathogenesis and Host Response in Helicobacter Infections, 5th July, Helsingor, Denmark; 2008.hlm. HP-76. 38.Lew E. Peptic ulcer disease. In: Greenberger NJ, editor. Current Diagnosis
and Treatment Gastroenterology, Hepatology, and Endoscopy. New York: McGraw Hill; 2009.hlm.175-83.
40.Eaton KA, Mefford M, Thevenot T. The role of T cell subsets and cytokines in the pathogenesis of Helicobacter pylori gastritis in mice. J Immunol. 2001;166:7456–61.
41.Zhao X, Wang Q, Qian Y, Song JL,. Ilex kudingcha C.J. Tseng (Kudingcha) prevents HCl/ethanol-induced gastric injury in Sprague-Dawley rats. Molecular Medicine Reports. 2013;7:1613-6.
42.Tanigawa T, Watanabe T, Higuchi K, Machida H, Okazaki H, Yamagami H, Watanabe K, Tominaga K, Fujiwara Y, Oshitani N, et al: Lansoprazole, a Proton Pump Inhibitor, Suppresses Production of Tumor Necrosis Factoralpha and Interleukin-1beta Induced by Lipopolysaccharide and Helicobacter Pylori Bacterial Components in Human Monocytic Cells via Inhibition of Activation of Nuclear Factor-kappaB and Extracellular Signal-Regulated Kinase. J Clin Biochem Nutr. 2009, 45(1):86–92.
43.Lee HJ, Han YM, Kim EH, Kim YJ, Hahm KB. A possible involvement of Nrf2-mediated heme oxygenase-1 up-regulation in protective effect of the proton pump inhibitor pantoprazole against indomethacin-induced gastric damage in rats. BMC Gastroenterology. 2012;12:143.
44.Rakananurak N, Sallapant S, Prueksapanich P, Somanawat K, Klaikaew N, Rerknimitr R, et al. Aloe vera Improved Gastric Injury on Nonsteroidal Anti-Inflammatory Drugs-Induced Gastropathy in Rats. Thai J Gastroenterol. 2013; 14(2):87-92.
45.Zhao X, Wang Q, Qian Y, Song JL,. Ilex kudingcha C.J. Tseng (Kudingcha) prevents HCl/ethanol-induced gastric injury in Sprague-Dawley rats. Molecular Medicine Reports. 2013;7:1613-6.
46.Eamlamnam K, Patumraj S, Visedopas N, et al. Effects of Aloe vera and sucralfate on gastric microcirculatory changes, cytokine levels and gastric ulcer healing in rats. World J Gastroenterol. 2006;12:2034-9.
48.Jainu M, Devi CSS. Gastroprotective action of Cissus quadrangularis extract against NSAID induced gastric ulcer: role of proinflammatory cytokines and oxidative damage. Chem Biol Interact. 2006;161:262–70.
49.Konturek PC
interleukin-1beta, tumor necrosis factor-alpha, and intercellular adhesion molecule-1 during healing of ischemia-reperfusion-induced gastric injury.
50.Fox JG, Megraud F. Helicobacter. In: Murray PR, editor. Manual of clinical microbiology. 9th ed. Pensylvania: Elsevier Mosby; 2007. hlm.947-62.
51.Israel DA, Peek RM. Review article: Pathogenesis of Helicobacter pylori-induced gastric inflammation. Aliment Pharmacol Ther. 2001;15:1271-90. 52.Bodger K, Crabtree JE. Helicobacter pylori and gastric inflammation.
British Med Bull. 1998;54:139-50.
53.Banerjee A, Mukhopadhyay AK, Paul S, Bhattacharyya A and Swarnakar
S. Unveiling the Intricacies of Helicobacter pylori-induced Gastric Inflammation: T Helper cells and Matrix Metalloproteinases at a Crossroad. In: Mozsik G, editor. Current Topics in Gastritis. Croatia: InTech Publishers; 2013. Chapter 7.
54.Furuta T, El-Omar EM, Xiao F, Shirai N, Takashima M, Sugimura H. Interleukin 1beta polymorphisms increase risk of hypochlorhydria and atrophic gastritis and reduce risk of duodenal ulcer recurrence in Japan. Gastroenterology. 2002;123(1):92-105.
55.Schottelius AJ, Mayo MW, Sartor RB, Baldwin AS. Interleukin-10 signaling blocks inhibitor of kappaB kinase activity and nuclear factor kappaB DNA binding. J Biol Chem. 1999;274:31868-74.
56.Al-Ashy R, Chakroun I, El-Sabban ME, Homaidan FR. The role of NF-kappaB in mediating the anti-inflammatory effects of IL-10 in intestinal epithelial cells. Cytokine. 2006; 36:1-8.
58.Yamada H, Aihara T, Okabe S. Mechanism for Helicobacter pylori stimulation of interleukin-8 production in a gastric epithelial cell line (MKN 28): roles of mitogen-activated protein kinase and interleukin-1beta. Biochem Pharmacol. 2001;61:1595-604.
59.Kim H, Lim JW, Kim KH. Helicobacter pylori-induced expression of interleukin-8 and cyclooxygenase-2 in AGS gastric epithelial cells: mediation by nuclear factor-kappaB. Scand J Gastroenterol. 2001;36:706-16.
60.Seo JH, Lim JW, Kim H, Kim KH. Helicobacter pylori in a Korean isolate activates mitogen-activated protein kinases, AP-1, and NF-kappaB and induces chemokine expression in gastric epithelial AGS cells. Lab Invest. 2004;84:49-62.
61.Robinson K, Kenefeck R, Pidgeon E, Shakib S, Patel S, Polson R, et al. Helicobacter pylori-induced peptic ulcer disease is associated with inadequate regulatory T-cell responses. Gut. 2008;57:1375-85.
62.Chu SH, Kim H, Seo JY, Lim JW, Mukaida N, Kim KH. Role of NF-kappaB and AP-1 on Helicobater pylori-induced IL-8 expression in AGS cells. Dig Dis Sci. 2003; 48:257-65.
63.Rani HAA, Fauzi A. Infeksi Helicobacter pylori. In: Sudoyo AW, Setiyohadi B, editor. Buku Ajar Penyakit Dalam. 6th ed. Jakarta: Penyakit Dalam Fakultas Kedokteran Universitas Indonesia: 2014. P925-9
64.Montemurro P, Nishioka H, Dundon WG, de Bernard M, Del Giudice G, Rappuoli R, et al. The neutrophil-activating protein (HP-NAP) of Helicobacter pylori is a potent stimulant of mast cells. Eur J Immunol. 2002;32:671-6.
65.Sander GB, Mazzoleni LE, Francesconi CF, Wortmann AC, Ott EA, Theil A, et al. Development and validation of a cross-cultural questionnaire to evaluate nonulcer dyspepsia: The Porto Alegre Dyspeptic Symptoms Questionnaire (PADYQ). Dig Dis Sci. 2004, 49(11):1822-9.
67.Sumadi IK. Hubungan Infeksi Helicobacter pylori dengan kadar pepsinogen II serum penderita dyspepsia ( Tesis ). Universitas udayana: 2005
68.Bode G, Rothenbacher D, Brenner H, Adler G. Helicobacter pylori and abdominal symptoms: a population-based study among preschool children in southern Germany. Pediatrics 1998;101:634-7.
69.Hirlan, Gastritis dalam Buku Ajar Ilmu Penyakit Dalam Edisi 5, Internal Publishing : 2009 ; 509-512.
70.Joshi A, Gupta SD, Ahuja V, Sharma MP. Symptom score does not correlate with gastritis grade and Helicobacter pylori infection in non ulcer dyspepsia. Trop Gastroenterol 2001;22:194-6.
71.Kasifoglu N, Akgun Y, Saricam T, Kiremitci A, Tercan. IL-8 Serum level in patients with Helicobacter pylori infection and relation between serological markers. African Journal of Microbiology 2009 ;11:822-25. 72.Khudhur S, Karhoot J, Khafi AJ, Mohsin J. Increase serum IL-8 level in
Iragi patients with Helicobacter pylori Cag A genotype infection. The Iraqi
Postgruate Meddical Journal 2011 Vol.10.
